We are live on
!
Find out more
Marshall Wace North America Portfolio holdings
AUM
$23.5B
Turnover
51.87%
1-Year Est. Return
46.46%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+46.46%
3 Year Est. Return
+108.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$24.1B
AUM Growth
-$134M
(-0.56%)
Cap. Flow
-$2.23B
Cap. Flow
% of AUM
-9.28%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
1,984
New
527
Increased
347
Reduced
445
Closed
587
Avg Time Held Equity + Options
0.6
years
Top 10 Avg Time Held Equity + Options
1.1
years
Top 20 Avg Time Held Equity + Options
1.1
years
Avg Time Held Equity only
0.6
years
Top 10 Avg Time Held Equity only
1.1
years
Top 20 Avg Time Held Equity only
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$157M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
Salesforce
CRM
|
+$135M |
| 4 |
IBM
IBM
|
+$130M |
| 5 |
Dell
DELL
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$313M |
| 2 |
Apple
AAPL
|
+$207M |
| 3 |
Intel
INTC
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$159M |
| 5 |
Centene
CNC
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.47% |
| 2 | Technology | 18% |
| 3 | Communication Services | 13.66% |
| 4 | Consumer Discretionary | 12.68% |
| 5 | Financials | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Amazon
AMZN
$2.7T
| $1.06B | 4.39% |
6,145,300
+281,240
| +5% | +$46.7M |
2013 Q3
31 quarters
|
|
2
Meta Platforms (Facebook)
META
$1.81T
| $794M | 3.3% |
2,284,360
+237,667
| +12% | +$76.2M |
2013 Q3
31 quarters
|
|
3
Alphabet (Google) Class C
GOOG
$4.12T
| $664M | 2.76% |
5,302,400
+720,560
| +16% | +$85.9M |
2018 Q1
13 quarters
|
|
|
4
Microsoft
MSFT
$3.93T
| $584M | 2.43% |
2,154,383
-1,229,730
| -36% | -$313M |
2017 Q1
17 quarters
|
|
5
Alphabet (Google) Class A
GOOGL
$4.17T
| $579M | 2.41% |
4,744,320
+689,740
| +17% | +$80.6M |
2017 Q1
17 quarters
|
|
|
6
Thermo Fisher Scientific
TMO
$255B
| $511M | 2.13% |
1,013,706
+286,186
| +39% | +$135M |
2018 Q4
10 quarters
|
|
|
7
Apple
AAPL
$5.01T
| $475M | 1.97% |
3,466,400
-1,593,794
| -31% | -$207M |
2013 Q2
32 quarters
|
|
8
Zoetis
ZTS
$32.8B
| $392M | 1.63% |
2,102,152
-566,009
| -21% | -$98.3M |
2013 Q2
32 quarters
|
|
9
Danaher
DHR
$161B
| $350M | 1.45% |
1,469,133
+439,460
| +43% | +$97.4M |
2013 Q4
30 quarters
|
|
10
UnitedHealth
UNH
$360B
| $312M | 1.3% |
778,191
+193,573
| +33% | +$77.2M |
2020 Q1
5 quarters
|
|
11
Boston Scientific
BSX
$64.3B
| $251M | 1.04% |
5,859,855
+1,089,462
| +23% | +$45.8M |
2017 Q1
17 quarters
|
|
|
12
Johnson & Johnson
JNJ
$616B
| $218M | 0.9% |
1,320,700
+947,557
| +254% | +$157M |
2020 Q4
2 quarters
|
|
|
13
Salesforce
CRM
$198B
| $215M | 0.89% |
878,971
+585,007
| +199% | +$135M |
2018 Q2
12 quarters
|
|
14
Steris
STE
$21.7B
| $187M | 0.78% |
904,677
+377,236
| +72% | +$76M |
2020 Q4
2 quarters
|
|
15
T-Mobile US
TMUS
$171B
| $184M | 0.77% |
1,273,303
+251,356
| +25% | +$34.7M |
2019 Q4
6 quarters
|
|
16
Linde
LIN
$230B
| $178M | 0.74% |
615,841
+53,510
| +10% | +$15.6M |
2019 Q4
6 quarters
|
|
17
Adobe
ADBE
$95.4B
| $174M | 0.72% |
297,754
-67,274
| -18% | -$34.7M |
2013 Q3
31 quarters
|
|
18
PayPal
PYPL
$48.5B
| $169M | 0.7% |
580,107
-256,940
| -31% | -$67.9M |
2018 Q4
10 quarters
|
|
19
TJX Companies
TJX
$162B
| $168M | 0.7% |
2,498,322
+1,568,536
| +169% | +$107M |
2018 Q3
11 quarters
|
|
20
AT&T
T
$161B
| $167M | 0.7% |
7,701,840
+729,529
| +10% | +$16.6M |
2020 Q4
2 quarters
|
|
21
Elevance Health
ELV
$92.9B
| $166M | 0.69% |
434,336
-341,135
| -44% | -$130M |
2017 Q2
16 quarters
|
|
22
Universal Health Services
UHS
$10.9B
| $165M | 0.69% |
1,127,123
+156,442
| +16% | +$23.6M |
2020 Q3
3 quarters
|
|
23
Accenture
ACN
$141B
| $161M | 0.67% |
546,190
+145,759
| +36% | +$41.7M |
2020 Q1
5 quarters
|
|
24
Dentsply Sirona
XRAY
$1.71B
| $156M | 0.65% |
2,463,633
+1,253,906
| +104% | +$82.6M |
2021 Q1
1 quarter
|
|
|
25
IBM
IBM
$219B
| $150M | 0.62% |
1,072,297
+951,640
| +789% | +$130M |
2020 Q4
2 quarters
|
|
Similar funds
NAM
Marshall Wace North America's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace North America held 1,984 positions worth $24.1B, down 0.56% from $24.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Marshall Wace North America withdrew a net $2.23B in Q2 2021, closing 587 positions and reducing 445 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $119M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 26% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Marshall Wace North America opened a new position in Syneos Health, Inc. Class A Common Stock worth $83.7M.
- Marshall Wace North America's largest Q2 2021 buy was Syneos Health, Inc. Class A Common Stock: 935,304 shares worth $83.7M.
- Marshall Wace North America added most to Johnson & Johnson in Q2 2021, an estimated $157M increase.
- Marshall Wace North America's biggest Q2 2021 reduction was Microsoft, cutting an estimated $313M.
- Marshall Wace North America fully exited State Street SPDR S&P 500 ETF Trust in Q2 2021, selling an estimated $119M.
- Marshall Wace North America's ten largest holdings make up 24% of its $24.1B portfolio in Q2 2021.
- Marshall Wace North America opened 527 new positions and closed 587 in Q2 2021.
- Marshall Wace North America's portfolio value fell 0.56% quarter-over-quarter to $24.1B.
Based on Marshall Wace North America's 13F filing for Q2 2021, filed 13 Aug 2021.